EpiCareSRT, Sensus Healthcare aim for mobile non-surgical skin cancer treatment service

EpiCareSRT™ (www.epicaresrt.com) announced today it has entered into a strategic partnership with Sensus Healthcare™ (www.sensushealthcare.com) to take new aim at skin cancer by providing the first mobile service to bring low-dose superficial radiation therapy directly to the point-of-care in dermatology offices.

EpiCareSRT's mobile services application of the Sensus SRT-100™ system, utilizing proprietary mobile x-ray technology, advances patient care.  It provides a new option for dermatologists to treat patients with basal cell and squamous cell carcinomas on an out-patient basis. When compared to other treatment modalities and surgical options, the SRT-100™ delivers high cure rates, low recurrence rates, no scarring and the convenience of treatment at the doctor's office.

"We are privileged to work with Sensus Healthcare in the fight against skin cancer," said Dale Ranney, CEO at EpiCareSRT. "We believe our solution improves the quality of care for the patient while increasing the value of the dermatologist's practice by bringing a very affordable, mobile non-surgical skin cancer treatment service to the point-of-care."

"We are very pleased to be working with EpiCareSRT. Bringing our technology to dermatology offices on a shared basis will give the dermatology community more treatment choices to offer their patients. Offering additional treatment options to patients will also allow Dermatologists to increase revenues and retain their patient base," said Steve Cohen, VP of Strategic Initiatives at Sensus Healthcare.

Superficial Radiation Therapy (SRT) is a clinically documented, well-established and reimbursable procedure. Sensus Healthcare's SRT-100™ system is optimal for mobile applications and meets stringent safety requirements set by the FDA, UL, ISO and CE Mark certification.

SOURCE Sensus Healthcare